{"id":11791,"date":"2018-07-27T21:46:58","date_gmt":"2018-07-27T21:46:58","guid":{"rendered":"https:\/\/clone.arsacs.com\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/"},"modified":"2021-07-20T14:43:09","modified_gmt":"2021-07-20T18:43:09","slug":"development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/","title":{"rendered":"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS &#8211; Dr. Michel Bouvier"},"content":{"rendered":"<p>The goal of this project is to develop small molecules that reverse the cellular phenotype of ARSACS into<br \/>\na drug that would stop the progression of the disease and\/or lead to clinical improvement. The project is<br \/>\na multidisciplinary collaboration between Dr Bernard Brais\u2019 (McGill Univ.) and Dr Michel Bouvier\u2019s (IRIC,<br \/>\nInstitute of Researcher in Immunology and Cancer, Univ. of Montreal) laboratories with the participation<br \/>\nof the High Throughput Screening (HTS) and Medicinal Chemistry core facilities at IRIC.<\/p>\n<p>Duration: One year<br \/>\nGrant: $150,000<\/p>\n<p>Contact<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg\" alt=\"\" width=\"150\" height=\"150\" class=\"alignleft size-thumbnail wp-image-3353\"><\/p>\n<p>Dr.Michel Bouvier, Institute for Research in Immunology and Cancer  (IRIC)<br \/>\nIRIC | Universit\u00e9 de Montr\u00e9al C.P. 6128, succursale Centre-ville, Montr\u00e9al (Qu\u00e9bec) H3C 3J7<br \/>\nTel: (514)-343-6319 ; Email: michel.bouvier@umontreal.ca<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The goal of this project is to develop small molecules that reverse the cellular phenotype of ARSACS into a drug that would stop the progression of the disease and\/or lead to clinical improvement. The project is a multidisciplinary collaboration between Dr Bernard Brais\u2019 (McGill Univ.) and Dr Michel Bouvier\u2019s (IRIC, Institute of Researcher in Immunology [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[25],"tags":[],"class_list":["post-11791","post","type-post","status-publish","format-standard","hentry","category-recherche-2018"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS - Dr. Michel Bouvier - ARSACS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS - Dr. Michel Bouvier - ARSACS\" \/>\n<meta property=\"og:description\" content=\"The goal of this project is to develop small molecules that reverse the cellular phenotype of ARSACS into a drug that would stop the progression of the disease and\/or lead to clinical improvement. The project is a multidisciplinary collaboration between Dr Bernard Brais\u2019 (McGill Univ.) and Dr Michel Bouvier\u2019s (IRIC, Institute of Researcher in Immunology [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/\" \/>\n<meta property=\"og:site_name\" content=\"ARSACS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100044457429916\" \/>\n<meta property=\"article:published_time\" content=\"2018-07-27T21:46:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-20T18:43:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg\" \/>\n<meta name=\"author\" content=\"ARSACS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ARSACS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/\"},\"author\":{\"name\":\"ARSACS\",\"@id\":\"https:\/\/arsacs.com\/#\/schema\/person\/93b66d6b897bfa131622d04b767b15f1\"},\"headline\":\"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS &#8211; Dr. Michel Bouvier\",\"datePublished\":\"2018-07-27T21:46:58+00:00\",\"dateModified\":\"2021-07-20T18:43:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/\"},\"wordCount\":134,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/arsacs.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg\",\"articleSection\":[\"Recherche 2018\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/\",\"url\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/\",\"name\":\"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS - Dr. Michel Bouvier - ARSACS\",\"isPartOf\":{\"@id\":\"https:\/\/arsacs.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg\",\"datePublished\":\"2018-07-27T21:46:58+00:00\",\"dateModified\":\"2021-07-20T18:43:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#primaryimage\",\"url\":\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg\",\"contentUrl\":\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/arsacs.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS &#8211; Dr. Michel Bouvier\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/arsacs.com\/#website\",\"url\":\"https:\/\/arsacs.com\/\",\"name\":\"Fondation de l'Ataxie Charlevoix-Saguenay\",\"description\":\"Research That Heals\",\"publisher\":{\"@id\":\"https:\/\/arsacs.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/arsacs.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/arsacs.com\/#organization\",\"name\":\"ARSACS\",\"url\":\"https:\/\/arsacs.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/arsacs.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/06\/logo_ARSACS_fr_flat.png\",\"contentUrl\":\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/06\/logo_ARSACS_fr_flat.png\",\"width\":291,\"height\":84,\"caption\":\"ARSACS\"},\"image\":{\"@id\":\"https:\/\/arsacs.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=100044457429916\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/arsacs.com\/#\/schema\/person\/93b66d6b897bfa131622d04b767b15f1\",\"name\":\"ARSACS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g\",\"caption\":\"ARSACS\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS - Dr. Michel Bouvier - ARSACS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/","og_locale":"fr_FR","og_type":"article","og_title":"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS - Dr. Michel Bouvier - ARSACS","og_description":"The goal of this project is to develop small molecules that reverse the cellular phenotype of ARSACS into a drug that would stop the progression of the disease and\/or lead to clinical improvement. The project is a multidisciplinary collaboration between Dr Bernard Brais\u2019 (McGill Univ.) and Dr Michel Bouvier\u2019s (IRIC, Institute of Researcher in Immunology [&hellip;]","og_url":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/","og_site_name":"ARSACS","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100044457429916","article_published_time":"2018-07-27T21:46:58+00:00","article_modified_time":"2021-07-20T18:43:09+00:00","og_image":[{"url":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg","type":"","width":"","height":""}],"author":"ARSACS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ARSACS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#article","isPartOf":{"@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/"},"author":{"name":"ARSACS","@id":"https:\/\/arsacs.com\/#\/schema\/person\/93b66d6b897bfa131622d04b767b15f1"},"headline":"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS &#8211; Dr. Michel Bouvier","datePublished":"2018-07-27T21:46:58+00:00","dateModified":"2021-07-20T18:43:09+00:00","mainEntityOfPage":{"@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/"},"wordCount":134,"commentCount":0,"publisher":{"@id":"https:\/\/arsacs.com\/#organization"},"image":{"@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#primaryimage"},"thumbnailUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg","articleSection":["Recherche 2018"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/","url":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/","name":"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS - Dr. Michel Bouvier - ARSACS","isPartOf":{"@id":"https:\/\/arsacs.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#primaryimage"},"image":{"@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#primaryimage"},"thumbnailUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg","datePublished":"2018-07-27T21:46:58+00:00","dateModified":"2021-07-20T18:43:09+00:00","breadcrumb":{"@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#primaryimage","url":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg","contentUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/arsacs.com\/"},{"@type":"ListItem","position":2,"name":"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS &#8211; Dr. Michel Bouvier"}]},{"@type":"WebSite","@id":"https:\/\/arsacs.com\/#website","url":"https:\/\/arsacs.com\/","name":"Fondation de l'Ataxie Charlevoix-Saguenay","description":"Research That Heals","publisher":{"@id":"https:\/\/arsacs.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/arsacs.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/arsacs.com\/#organization","name":"ARSACS","url":"https:\/\/arsacs.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/arsacs.com\/#\/schema\/logo\/image\/","url":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/06\/logo_ARSACS_fr_flat.png","contentUrl":"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/06\/logo_ARSACS_fr_flat.png","width":291,"height":84,"caption":"ARSACS"},"image":{"@id":"https:\/\/arsacs.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100044457429916"]},{"@type":"Person","@id":"https:\/\/arsacs.com\/#\/schema\/person\/93b66d6b897bfa131622d04b767b15f1","name":"ARSACS","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e3b226aca332e58d41ec45fa04620bcbd869d2e4e661cacde31eeb3ae6a5708d?s=96&d=mm&r=g","caption":"ARSACS"}}]}},"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=11791"}],"version-history":[{"count":1,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11791\/revisions"}],"predecessor-version":[{"id":14907,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11791\/revisions\/14907"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=11791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=11791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=11791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}